Trials / Unknown
UnknownNCT04574934
Effect of Aquatic Therapy on Pulmonary Functions in Patients With Muscular Dystrophy
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- South Valley University · Academic / Other
- Sex
- All
- Age
- 4 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
This study aimed to assess the efficacy of aquatic therapy on pulmonary functions in patients with muscular dystrophy.
Detailed description
Muscular dystrophy (MD) is a group of muscle diseases that results in increasing weakening and breakdown of skeletal muscles over time. The disorders differ in which muscles are primarily affected, the degree of weakness, how fast they worsen, and when symptoms begin. Many people will eventually become unable to walk. Some types are also associated with problems in other organs. The muscular dystrophy group contains thirty different genetic disorders that are usually classified into nine main categories or types. The signs and symptoms consistent with muscular dystrophy are: progressive muscular wasting, poor balance, scoliosis (curvature of the spine and the back), progressive inability to walk, waddling gait, Calf deformation, Limited range of movement,respiratory difficulty, cardiomyopathy and muscle spasms
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | aquatic therapy | Aquatic therapy refers to water-based treatments or exercises of therapeutic intent, in particular for relaxation, fitness, and physical rehabilitation. Treatments and exercises are performed while floating, partially submerged, or fully submerged in water. Many aquatic therapy procedures require constant attendance by a trained therapist and are performed in a specialized temperature-controlled pool. Rehabilitation commonly focuses on improving the physical function associated with illness, injury, or disability |
Timeline
- Start date
- 2020-06-01
- Primary completion
- 2020-10-01
- Completion
- 2020-10-01
- First posted
- 2020-10-05
- Last updated
- 2020-10-05
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04574934. Inclusion in this directory is not an endorsement.